-
Study aim
-
the effect of Ganoderma lucidum supplementation on anthropometric indices, chemical biomarkers and blood pressure in overweight people
-
Design
-
A clinical trial with a control group, with a parallel, double-blind, randomized, phase 3 group on 72 patients, used the rand function of Excel software for randomization.
-
Settings and conduct
-
The study was performed in Salahuddin Ayoubi Hospital in Baneh. They were randomly divided into two groups of intervention and control. Patients who were eligible for the study were randomly divided into two groups of placebo and medicine. Whether the drug was a placebo or an intervention was unknown but the researcher was aware. Patients and drugs were coded by the researcher.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:Age 60 to 18 years, personal satisfaction,Body mass index 25 to 29.9, no underlying diseases interfering with weight loss and drug use, use of any type of weight loss and fat or blood pressure monitor and blood sugar control, non-pregnancy and lactation.Exclusion criteria:taking Weight loss supplements,following a diet to lose weight,diseases associated with metabolic changes such as thyroid disease,taking drug that inhibit platelet aggregation (such as aspirin or warfarin) ,unavailability of any reason
-
Intervention groups
-
Intervention group: Patients received 3 capsules of Ganoderma daily, each capsule containing 220 mg of complete powder of Ganoderma lucidum and 30 mg of pure aqueous extract of Ganoderma lucidum for 6 weeks. Control group: Patients received 3 capsules daily, each containing 250 mg of wheat flour for 6 weeks.
-
Main outcome variables
-
Body mass index(BMI) , weight, waist circumference, hip circumference, waist to hip ratio, arm circumference, total cholesterol concentration,Low density lipoprotein(LDL),High density lipoprotein(HDL) , triglyceride, blood sugar, blood pressure,Physical activity